Colon peritoneal metastasis

Who will benefit most:  Patient selection and disease evaluation tools Colorectal cancer. M Pocard  

Métastases péritonéale colique quels patients opérer – chimio ip ?. M Pocard

What’s new in CRS and HIPEC for colorectal carcinomatosis. M Pocard

Prevention of peritoneal carcinomatosis : actual results and future solutions for the surgeon. M Pocard.

A UNICANCER phase III trial of Hyperthermic Intra- peritoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Carcinomatosis. 
François Quenet,MD, Dominique Elias, MD, PhD, Lise Roca, M.Sc., Diane Goéré , MD, PhD, Laurent Ghouti, MD, Marc Pocard, MD, PhD, Olivier Facy, MD, PhD, Catherine Arvieux, MD, PhD, Gérard Lorimier, MD, Denis Pezet, MD, PhD, Frédéric Marchal, MD, PhD, Valeria Loi, MD, PhD, Pierre Meeus, MD, Hélène de Forges, PhD, Trevor Stanbury, PhD, Jacques Paineau, MD, PhD, Olivier Glehen, MD, PhD. 

Cas clinique 1: Carcinose péritonéalePr Marc Pocard

Legal policies

Copyright 2020